文献速递关节外科

初次全髋关节置换术后患者结局是否因年龄而异?

Do Patient Outcomes Vary by Patient Age Following Primary Total Hip Arthroplasty?
PubMed 文献 · J Arthroplasty · 2022-03-12

研究基于FORCE-TJR前瞻性多中心队列的7934例单侧初次全髋关节置换患者,按年龄分层比较术前及术后1年患者报告结局。结果显示各年龄组均有大幅改善,虽部分评分差异有统计学意义,但均未达最小临床重要差异,年龄相关的临床差异不显著。

要点

  • 年轻患者(<55岁)术前疼痛、功能和生活质量评分较其他年龄组更差。
  • 术后1年,年轻患者疼痛和生活质量略差但功能评分更好,且疼痛和功能评分改善幅度更大。
  • 各年龄组术后1年评分差异及改善幅度差异有统计学意义(P < .001),但均未达最小临床重要差异。

核心结论

  • 不同年龄组患者在疼痛缓解、功能改善和生活质量方面虽有统计学显著差异,但无临床显著差异。
  • 全髋关节置换术在所有4个年龄组中均通过减轻疼痛和改善功能提高生活质量,患者报告结局评分改善幅度大(>2个标准差),术后1年无临床显著的年龄相关差异。

研究设计与样本

  • 前瞻性、多中心队列研究,纳入FORCE-TJR比较效益 consortium 中7934例单侧初次全髋关节置换患者。
  • 收集人口学数据、合并症和患者报告结局指标(包括HOOS、HOOS-12、HOOS JR、SF-36的PCS和MCS),于术前和术后1年评估。
  • 按年龄分层:<55岁(年轻成人)、55-64岁(年长成人)、65-74岁(早期老年)、≥75岁(晚期老年),比较4组间疼痛、功能和生活质量的差异。
  • 采用多变量回归模型(95%置信区间)评估年龄作为初次全髋关节置换术后1年HOOS疼痛和功能评分预测因素的作用。

主要发现

  • 术前,年轻患者(<55岁)报告的疼痛、功能和生活质量较其他3个年龄组更差。
  • 术后1年,年轻患者(<55岁)报告的疼痛和生活质量略差,但功能评分优于3个年长组。
  • 年轻患者(<55岁)从基线到1年的疼痛和功能评分改善幅度高于年长组;生活质量评分改善在4个年龄组间无差异。
  • 术后1年评分差异(范围2.74至8.46)和基线至1年评分改善幅度(范围1.9至5.85)虽有统计学意义(P < .001),但未达最小临床重要差异(MCID)。
  • 多变量回归分析显示年龄是术后1年疼痛的显著预测因素,但不是功能的显著预测因素;与年轻患者(<55岁)相比,年长患者(≥75岁)术后1年HOOS疼痛评分预计高4.38分(疼痛更轻),但差异远低于MCID,无临床意义。

关键数值与推荐

  • 年龄分层标准:<55岁、55-64岁、65-74岁、≥75岁。
  • 术后1年评分差异范围2.74至8.46,基线至1年评分改善幅度范围1.9至5.85,均P < .001,但未达MCID。
  • 年长患者(≥75岁)较年轻患者(<55岁)术后1年HOOS疼痛评分预计高4.38分(疼痛更轻),差异低于MCID。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Multiple authors have sought to determine what patient characteristics influence outcome after total hip arthroplasty (THA). Age has shown no effect on outcome in some evaluations, while others have reported higher functional improvement in younger patients. The aim of this study was to determine if outcome after THA varies based on patient age. METHODS: A prospective, multicenter cohort of 7,934 unilateral primary THA patients from the FORCE-TJR comparative effectiveness consortium was evaluated. Demographic data, comorbid conditions, and Patient-Reported Outcome Measures, including (HOOS), HOOS-12, HOOS JR, and SF-36 (PCS) and (MCS), were collected preop and at 1-year postop. Descriptive statistics were generated, stratified by age (<55 years [younger adult], 55-64 years [older adult], 65-74 years [early elder], and ≥75 years [late elder]), and differences in pain, function, and quality of life among the 4 age groups were evaluated. A multivariate regression model with 95% confidence interval (CI) was used to assess the role of patient age as a predictive factor for HOOS pain and function scores reported 1 year after primary THA. RESULTS: Prior to surgery, younger patients (<55 years) reported worse pain, function, and quality of life than the other 3 patient groups. At 1 year after THA, younger patients (<55 years) reported slightly worse pain and quality of life but better function scores than the 3 older patients' groups. Younger patients (<55 years) achieved higher baseline to 1-year pain, and function score changes when compared to the older patients' groups. The quality of life score changes was not different among the 4 age groups. The differences in 1-year postop scores (ranging from 2.74 to 8.46) and the magnitude of score changes from baseline to 1 year (ranging from 1.9 to 5.85), although statistically significant (P < .001), did not reach the minimal clinically important difference (MCID). The multivariate regression analysis shows that age is a significant predictor for pain at 1 year but not for function. Although HOOS pain score is predicted to be higher by 4.38 points (less pain) 1 year after THA in older patients (≥75), when compared to younger patients (<55 years), again the difference is well below the MCID and is clinically insignificant. CONCLUSION: Although there are statistically significant differences in pain relief, functional improvement, and quality of life between younger and older patients among different patients' age groups, there is no clinically significant difference. THA provides an improvement in quality of life by decreasing pain and increasing function in all 4 age groups, with large improvements in Patient-Reported Outcome Measures scores (>2 standard deviations) without clinically significant age-related differences in THA outcome at 1 year.

来源:J Arthroplasty,查看原文。版权归原作者所有。

引用

  1. Ayers DC, Yousef M, Zheng H, et al. Do Patient Outcomes Vary by Patient Age Following Primary Total Hip Arthroplasty? J Arthroplasty. 2022. PMID: 35292339. doi:10.1016/j.arth.2022.03.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。